Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trialMehreen S. Datoo, Nsajigwa Misidai, Alassane Dicko et al.|The Lancet|2024Cited by 345
Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, MaliFatou Diawara, Alassane Dicko, Laura C. Steinhardt et al.|Malaria Journal|2017Cited by 127
Sporozoite immunization: innovative translational science to support the fight against malariaThomas L. Richie, Stephen L. Hoffman, L. W. Preston Church et al.|Expert Review of Vaccines|2023Cited by 46
Delivery strategies for malaria vaccination in areas with seasonal malaria transmissionJane Grant, Jayne Webster, Halimatou Diawara et al.|BMJ Global Health|2023Cited by 11
Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distributionHalimatou Diawara, Lesong Conteh, Patrick Walker et al.|Malaria Journal|2021Cited by 10